Novavax, Inc. (NVAX)

NASDAQ: NVAX · IEX Real-Time Price · USD
21.00
-1.44 (-6.42%)
At close: Sep 23, 2022 4:00 PM
21.08
+0.08 (0.38%)
After-hours: Sep 23, 2022 7:59 PM EDT
-6.42%
Market Cap 1.64B
Revenue (ttm) 1.29B
Net Income (ttm) -1.48B
Shares Out 78.22M
EPS (ttm) -17.51
PE Ratio n/a
Forward PE 0.94
Dividend n/a
Ex-Dividend Date n/a
Volume 5,273,361
Open 21.84
Previous Close 22.44
Day's Range 20.46 - 22.37
52-Week Range 20.46 - 249.04
Beta 1.64
Analysts Buy
Price Target 124.03 (+490.6%)
Earnings Date Nov 2, 2022

About NVAX

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate... [Read more...]

Industry Biotechnology
IPO Date Dec 5, 1995
CEO Stanley Erck
Employees 1,541
Stock Exchange NASDAQ
Ticker Symbol NVAX
Full Company Profile

Financial Performance

In 2021, Novavax's revenue was $1.15 billion, an increase of 141.02% compared to the previous year's $475.60 million. Losses were -$1.74 billion, 316.9% more than in 2020.

Financial Statements

Analyst Forecast

According to 14 analysts, the average rating for NVAX stock is "Buy." The 12-month stock price forecast is 124.03, which is an increase of 490.62% from the latest price.

Price Target
$124.03
(490.62% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Why Novavax (NVAX) Stock Was Down 13% on Thursday

Novavax (NVAX) sinks to a new record level 52-week low after analysts at JP Morgan cut the 12-month target price on the stock by more than $100.

1 day ago - Zacks Investment Research

Pharma Giants Moderna And Novavax Trend Lower In This Pattern: What's Going On? - Moderna (NASDAQ:MRNA)

Moderna Inc. (NASDAQ: MRNA) and Novavax Inc. (NASDAQ: NVAX) were trading down over 2% and 4%, respectively in the premarket Friday despite both stocks showing signs a bounce could be in the cards.

Other symbols: MRNA
1 day ago - Benzinga

Novavax stock dives after JPMorgan downgrades shares

This segment originally aired on September 22, 2022. Yahoo Finance Live's Julie Hyman discusses Novavax stock performance after JPMorgan downgrades its shares to Underweight from Neutral.

1 day ago - Yahoo Finance

Why Novavax Stock Is Plunging This Week

Novavax has some serious short-term challenges but could still have growth opportunities in the future.

2 days ago - The Motley Fool

Here Are Novavax's U.S. Vaccination Numbers — And They're Bleak

Novavax stock is trading at a two-year low amid slowly ramping use of its Covid vaccine, dubbed Nuvaxovid, in the U.S. The post Here Are Novavax's U.S. Vaccination Numbers — And They're Bleak appeared f...

2 days ago - Investors Business Daily

Why Novavax Stock Hit a Fresh 52-Week Low Today

The biotech's shares are crumbling today following an analyst downgrade.

2 days ago - The Motley Fool

Novavax stock extends plunge after J.P. Morgan turns bearish, on expectations of more guidance cuts

Shares of Novavax Inc. NVAX, -7.46% slumped 7.1% in morning trading Thursday, to extend their recent plunge toward a near 2 1/2-year low, after J.P. Morgan threw in the towel on the maker of the COVID-1...

2 days ago - Market Watch

Why Is Novavax (NVAX) Stock Falling Today?

Novavax (NASDAQ: NVAX ) stock fell 6% on Sept. 21, and kept falling overnight, after a JP Morgan Chase analyst cut his price target from over $100/share down to just $27 with an “underperform” rating.

2 days ago - InvestorPlace

Vaccine Stocks Down After Biden Says Pandemic is Over

BioNTech (BNTX), Moderna (MRNA) and Novavax (NVAX) stocks decline 8.6%, 7.1% and 6.5%, respectively.

Other symbols: BNTXMRNAPFE
4 days ago - Zacks Investment Research

Is Trending Stock Novavax, Inc. (NVAX) a Buy Now?

Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

4 days ago - Zacks Investment Research

Vaccine Stocks: Down but Not Out?

Whether the pandemic is over or not, plenty of people are still looking for protection against COVID-19.

Other symbols: BNTXMRNA
4 days ago - The Motley Fool

Why Novavax and Johnson & Johnson Stocks Slipped Today

The latest pronouncements by the president aren't exactly doing the two healthcare companies any favors.

Other symbols: JNJ
5 days ago - The Motley Fool

Why Are Vaccine Stocks MRNA, PFE, NVAX, BNTX Down Today?

It's a mixed day for the stock market, but it's not a good day for vaccine stocks. Across the board, these names are getting sold.

Other symbols: MRNAPFEBNTX
5 days ago - InvestorPlace

Moderna, BioNTech, and Novavax plunge after President Biden says the COVID-19 pandemic 'is over'

"The pandemic is over. We still have a problem with COVID. We're still doing a low of work on it. But the pandemic is over," Biden said.

Other symbols: BNTXMRNA
5 days ago - Business Insider

Vaccine stocks Pfizer, BioNTech, Moderna and Novavax slide after Biden says pandemic is over

Stocks of the three key vaccine makers fell sharply Monday, after President Joe Biden said the pandemic is over, in an interview with "60 Minutes" that aired on Sunday. Moderna Inc. MRNA, -9.41% fell 9....

Other symbols: BNTXMRNAPFE
5 days ago - Market Watch

Why BioNTech, Moderna And Novavax Shares Are Diving

BioNTech SE - ADR (NASDAQ: BNTX), Moderna Inc (NASDAQ: MRNA) and Novavax, Inc. (NASDAQ: NVAX) are all trading lower during Mo

Other symbols: BNTXMRNA
5 days ago - Benzinga

Novavax says its COVID vaccine is now available in Israel for use in people aged 12 and older

Novavax Inc. NVAX, said Friday that Israel has granted an import and use permit for the company's COVID vaccine for use in people aged 12 and older. The vaccine is protein based, using a more traditiona...

1 week ago - Market Watch

Novavax Nuvaxovid™ COVID-19 Vaccine Receives Expanded Emergency Use Authorization in Taiwan for Use in Adolescents Ag...

GAITHERSBURG, Md. , Sept. 16, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious disea...

1 week ago - PRNewsWire

Novavax Nuvaxovid™ COVID-19 Vaccine Now Available in Israel for Individuals Aged 12 and Older

The Israeli Advisory Committee on Epidemics has recommended that Nuvaxovid™ be approved for ages 12 and older as a primary series and as a heterologous booster for those previously vaccinated with mRNA ...

1 week ago - PRNewsWire

Novavax (NVAX) Flat As Market Sinks: What You Should Know

Novavax (NVAX) closed the most recent trading day at $32.55, making no change from the previous trading session.

1 week ago - Zacks Investment Research

Novavax (NVAX) Gets EU Nod for COVID-19 Booster Jab in Adults

Novavax (NVAX) gets authorization from the European Union to use its COVID-19 vaccine as a booster dose in adults.

1 week ago - Zacks Investment Research

Novavax and Serum Institute of India Announce Full Product Registration in South Africa of Novavax COVID-19 Vaccine a...

GAITHERSBURG, Md. , Sept. 13, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious disea...

1 week ago - PRNewsWire

Novavax's COVID-19 booster is now authorized in Europe

Shares of Novavax Inc. NVAX, +1.83% were up 2.4% in trading on Monday after the company said its COVID-19 booster has been authorized in Europe for adults. Novavax's stock has declined 77.3% so far this...

1 week ago - Market Watch

Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Conditional Marketing Authorization in the European Union for Us...

Nuvaxovid™ is now authorized in the EU for use in adults aged 18 and older as a booster regardless of previous vaccine history GAITHERSBURG, Md. , Sept. 12, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: N...

1 week ago - PRNewsWire

3 Stocks Expecting Good News From the FDA

Here are the upcoming catalysts for Mirati Therapeutics, Novavax, and Heron Therapeutics.

Other symbols: HRTXMRTX
1 week ago - The Motley Fool